Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Retinoblastoma
Stage/Subtype:  intraocular retinoblastoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Results 1-10 of 10 for your search:
Start Over
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 05-122, MSKCC-05122, NCT00445965
Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: J1071, NA_00040637, NCT01293539
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: SJRET6, NCI-2013-00409, NCT01783535
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 29
Sponsor: Other
Protocol IDs: IRB00078790, NCT02390843
A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 08-885, no grant, NCT00857519
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 10 and under
Sponsor: Other
Protocol IDs: RELRB1, NCT00980551
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Phase: No phase specified
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Phase: No phase specified
Type: Treatment
Status: Active
Age: 5 to 21
Sponsor: Other
Protocol IDs: 201209088, NCT01661400
Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Children
Sponsor: NCI, Other
Protocol IDs: ARET12P1, NCI-2014-00618, COG-ARET12P1, U10CA098543, U10CA180886, NCT02097134
Alternating Systemic Chemotherapy and Intra-Arterial Melphalan Chemotherapy in Children With Intra-Ocular Retinoblastoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 months and over
Sponsor: Other
Protocol IDs: 13087, NCT02116959
Start Over